Skip to main content
Top
Published in: Diabetology & Metabolic Syndrome 1/2015

01-12-2015 | Meeting abstract

Young leaders doing diabetes education in a school

Authors: Matheus Chaluppe de Oliveira, Ronaldo José Pineda Wieselberg, Mark Thomaz Ugliara Barone, Patrícia Vieira de Luca, Viviana Giampaoli

Published in: Diabetology & Metabolic Syndrome | Special Issue 1/2015

Login to get access

Excerpt

Although type 1 diabetes mellitus (DM) is one of the most common chronic diseases in children, school staff and students know very little about it. Most of what they know are misconceptions, like: “the person who has it cannot eat sugar”, or “it is a disease of old people”. Due to this lack of knowledge, they sometimes refuse to have students with DM, to assist them with their self-care routine, or are unable to help in an emergency. One of the Brazilian Young Leaders in Diabetes (YLD) made, as its conclusion YLD Training project, a diabetes information campaign in his former school. …
Metadata
Title
Young leaders doing diabetes education in a school
Authors
Matheus Chaluppe de Oliveira
Ronaldo José Pineda Wieselberg
Mark Thomaz Ugliara Barone
Patrícia Vieira de Luca
Viviana Giampaoli
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue Special Issue 1/2015
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/1758-5996-7-S1-A185

Other articles of this Special Issue 1/2015

Diabetology & Metabolic Syndrome 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine